Laboratory Safety of Dupilumab in Patients Aged 6 to < 12 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial

Amy S Paller, Andreas Wollenberg, Elaine C Siegfried, Diamant Thaci, Michael J. Cork, Peter Arkwright, Melinda Gooderham, Xian Sun, John T O'Malley, Faisal Khokhar, Jignesh Vakil, Ashish Bansal, Karli Rosner, Brad Shumel, Noah A. Levit

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Laboratory Safety of Dupilumab in Patients Aged 6 to < 12 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology